Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report
- PMID: 35980544
- PMCID: PMC9388704
- DOI: 10.1186/s40792-022-01514-6
Granulocyte colony-stimulating factor-associated aortitis in a woman with breast cancer: a case report
Abstract
Background: Granulocyte colony-stimulating factor (G-CSF) is increasingly used to prevent chemotherapy-associated febrile neutropenia. Generally, aortitis is not considered a side effect of G-CSF and is thought to be extremely rare. Aortitis is an inflammation of the aorta and occurs mainly in connective tissue diseases (Takayasu arteritis, giant cell arteritis, etc.) and infectious diseases (bacterial endocarditis, syphilis, etc.). We report herein a rare case of G-CSF associated with aortitis in a woman with breast cancer.
Case presentation: Here, we present a case involving a 63-year-old woman with luminal type stage IIa breast cancer. The patient's treatment was initiated with docetaxel and cyclophosphamide, with pegfilgrastim (PEG-G) as support. After PEG-G administration on day 3, the patient developed an intermittent fever of up to 39.4 °C on day 10 and visited our outpatient clinic on day 13 with persistent high fever. Laboratory tests revealed a high neutrophil count (14,000/μL) and a high C-reactive protein (CRP) level (42.8 mg/dL) without any other abnormalities. Contrast-enhanced computed tomography scanning revealed soft tissue thickening with weak enhancement around the wall of the thoraco-abdominal aorta, aortic arch and left subclavian artery. The patient did not respond to antimicrobial agents. On the basis of these observations, the patient was diagnosed with PEG-G-induced aortitis, and her condition rapidly improved without corticosteroids.
Conclusions: Clinicians should be aware of aortitis as a potential complication in patients undergoing G-CSF chemotherapy. In cases with persistent high fever after PEG-G administration, and in the absence of infection, aortitis should be suspected.
Keywords: Aortitis; Breast cancer; Granulocyte colony-stimulating factor (G-CSF); Pegfilgrastim.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures

Similar articles
-
Granulocyte-colony stimulating factor-associated aortitis in a woman with advanced breast cancer: a case report and review of the literature.BMC Cancer. 2019 Dec 16;19(1):1217. doi: 10.1186/s12885-019-6403-9. BMC Cancer. 2019. PMID: 31842789 Free PMC article. Review.
-
Drug-induced aortitis of the subclavian artery caused by pegfilgrastim: a case report.Surg Case Rep. 2021 Aug 26;7(1):197. doi: 10.1186/s40792-021-01282-9. Surg Case Rep. 2021. PMID: 34448091 Free PMC article.
-
Successful treatment of G-CSF-related aortitis with prednisolone during preoperative chemotherapy for breast cancer: a case report.Surg Case Rep. 2021 Jan 14;7(1):23. doi: 10.1186/s40792-021-01111-z. Surg Case Rep. 2021. PMID: 33443626 Free PMC article.
-
Granulocyte colony-stimulating factor-associated aortitis in a man with advanced prostate cancer.IJU Case Rep. 2025 Feb 13;8(3):190-193. doi: 10.1002/iju5.12835. eCollection 2025 May. IJU Case Rep. 2025. PMID: 40336734 Free PMC article.
-
G-CSF-induced aortitis: Two cases and review of the literature.Autoimmun Rev. 2019 Jun;18(6):615-620. doi: 10.1016/j.autrev.2018.12.011. Epub 2019 Apr 5. Autoimmun Rev. 2019. PMID: 30959218 Review.
Cited by
-
Literature review analysis of aortitis induced by granulocyte-colony stimulating factor.Front Pharmacol. 2024 Dec 18;15:1487501. doi: 10.3389/fphar.2024.1487501. eCollection 2024. Front Pharmacol. 2024. PMID: 39744136 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous